TECHWIRE 30
(CIX: WRAL30)  1,016.16  down arrow-1.58  (-0.16 %)  Updated: 03:59 PM EST, Feb 11 2016
(NQ: Apple)  93.65  down arrow-0.62  (-0.66 %)  Updated: 03:59 PM EST, Feb 11 2016
(NY: QUINTILES)  59.00  up arrow+0.65  (1.11 %)  Updated: 03:59 PM EST, Feb 11 2016
(OP: BASF SE)  64.80  up arrow+0.15  (0.24 %)  Updated: 03:59 PM EST, Feb 11 2016
(NQ: BioCryst)  1.66  down arrow-0.14  (-7.78 %)  Updated: 04:00 PM EST, Feb 11 2016
(NQ: BioDelivery)  3.53  up arrow+0.04  (1.15 %)  Updated: 03:59 PM EST, Feb 11 2016
(NQ: CEMP)  16.53  down arrow-0.07  (-0.42 %)  Updated: 03:59 PM EST, Feb 11 2016
(NQ: Cisco)  24.68  up arrow+2.17  (9.64 %)  Updated: 03:59 PM EST, Feb 11 2016
(NQ: Cree)  28.44  down arrow-0.86  (-2.94 %)  Updated: 04:00 PM EST, Feb 11 2016
(NQ: DARA)  0.88    (0 %)  Updated: 08:10 PM EST, Dec 04 2015
(NY: EMC)  24.16  down arrow-0.39  (-1.59 %)  Updated: 03:59 PM EST, Feb 11 2016
(NQ: Extreme Networks)  2.35  down arrow-0.13  (-5.24 %)  Updated: 04:00 PM EST, Feb 11 2016
(NQ: Facebook)  101.91  up arrow+0.91  (0.9 %)  Updated: 04:00 PM EST, Feb 11 2016
(NY: GLAXOSMITHKLINE)  39.16  up arrow+0.03  (0.08 %)  Updated: 03:59 PM EST, Feb 11 2016
(NQ: Alphabet)  682.48  down arrow-1.64  (-0.24 %)  Updated: 03:59 PM EST, Feb 11 2016
(NY: IBM)  117.83  down arrow-2.36  (-1.96 %)  Updated: 03:59 PM EST, Feb 11 2016
(NY: LH)  101.31  down arrow-3.28  (-3.14 %)  Updated: 03:59 PM EST, Feb 11 2016
(OP: Lenovo Group)  15.91  down arrow-0.73  (-4.39 %)  Updated: 03:59 PM EST, Feb 11 2016
(NY: MRK)  48.82  down arrow-0.71  (-1.43 %)  Updated: 03:59 PM EST, Feb 11 2016
(NQ: Microsoft)  49.63  down arrow-0.08  (-0.16 %)  Updated: 04:00 PM EST, Feb 11 2016
(NQ: NetApp)  21.73  down arrow-0.65  (-2.9 %)  Updated: 03:59 PM EST, Feb 11 2016
(NY: NOVARTIS AG)  72.21  down arrow-0.78  (-1.07 %)  Updated: 03:59 PM EST, Feb 11 2016
(OP: Novozymes A/S)  41.16  down arrow-0.16  (-0.38 %)  Updated: 03:59 PM EST, Feb 11 2016
(NY: Pfizer)  29.14  down arrow-0.35  (-1.19 %)  Updated: 03:59 PM EST, Feb 11 2016
(NQ: POZN)  5.94    (0 %)  Updated: 08:10 PM EST, Feb 05 2016
(NY: Red Hat)  61.96  down arrow-1.58  (-2.49 %)  Updated: 03:59 PM EST, Feb 11 2016
(NQ: BBRY)  6.62  down arrow-0.03  (-0.38 %)  Updated: 04:00 PM EST, Feb 11 2016
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  11.81  down arrow-0.22  (-1.83 %)  Updated: 03:59 PM EST, Feb 11 2016

Posts tagged “PPD”

January 25

Fred Eshelman to receive CED's Life Science Leadership Award

Fred Eshelman   Veteran entrepreneur, philanthropist and investor Fred Eshelman will receive the Life Science Leadership Award at the 25th annual CED Life Science Conference in March.

Updated January 14

Premium Lock X-Co answer: PPD spins off X-Chem, which it acquired in 2014

X-Chem PPD has wrapped up the spin-off X-Chem to its private equity owners, the Wilmington company says. The X-Chem deal was behind the "X-Co Holdings LP" mystery that unfolded after an SEC filing.

Updated January 14

Premium Lock Report: CRO industry to grow at 6% a year through 2022

Medical research The contract research organization business, which has a big hub in the Triangle with numerous major players based in the region, is headed toward seven years of plenty, according to a new report.

Updated January 14

Premium Lock Mysterious 'X-Co' in Wilmington raises $71M in PPD spinoff

Questions Just in time for the return of the "X Files" on Fox, a mysterious "X-Co Holdings" company has emerged from the shadows in Wilmington, N.C. X-Co has numerous links to PPD and its private equity owners. PPD spun off a company, X-Chem.

Updated December 15, 2015

Premium Lock Is PPD for sale with $7-8B price tag? Still no comment

PPD Is life science services company PPD for sale? A Reuters news report says it is, but so far the company isn't saying anything. Neither are the two private equity firms that own the Wilmington-based company.

December 3, 2015

Premium Lock INC Research wins prestigious award as top CRO

INC Research INC Research, a fast-growing life science contract research organization, is the winner of the prestigious Scrip Award as the top CRO for 2015. Quintiles and PPD were also finalists.

Updated April 10, 2015

Premium Lock Validic's fast growth; LinkedIn's $1.5B buy; new PPD joint venture; Liquidia demos its tech; Zynga founder returns

Bulldog In today's Bulldog wrapup of technology and life science news: Startup Validic reports fast growth; LinkedIn's big acquisition; PPD forms a joint venture in Japan; Liquidia demos at vaccine congress; and Zynga's founder returns as CEO.

September 26, 2014

Premium Lock PPD buys remaining interest in firm it has owned since 2010

PPD Wilmington-based PPD, which has a large presence in the Triangle, on Thursday bought the remaining minority interest in a Massachusetts firm which it originally acquired in 2010.

April 29, 2014

Premium Lock From our archives: The Fred Eshelman saga includes one-person startup at PPD to Wilmington's Walk of Fame and now a $1.1B sale of Furiex

Fred Eshelman Looking back at Fred Eshelman's career: A 2009 blog post recapped a tumultuous year for Eshelman and PPD in which the company's stock was hammered and he stepped down as CEO to become executive chairman. But the year was capped with a salute. From there, Eshelman has continued to make headlines.

August 28, 2013

Premium Lock PPD acquires Acurian to improve recruitment, retention in clinical trials

David Simmons M&A dealmaking in the contract research organization sector strikes again as PPD buys a company. Read how the Acurian acquisition helps Wilmington-based PPD.

November 30, 2012

Premium Lock PPD lands top technology honor in life science awards

PPD PPD's 3D technology for global training in clinical trials receives the Best Technological Development in Clinical Trials honor from Scrip, an international life science media and technology firm.

November 21, 2012

Premium Lock Oxygen Biotherapeutics picks PPD to run clinical trial

PPD Oxygen Biotherapeutics picks PPD as the contract research organization to run a Phase 2 clinical trial on a proposed treatment for traumatic brain injury.

October 25, 2012

Premium Lock $9M in new funding positions Clinipace for more deals

Clinical research organization Clinipace's fundraising haul today of $9 million puts it in a position to do more of what the Morrisville company has been doing in over the last two years - finding and acquiring companies.

Clinipace's website touts its growing reach, expertise Clinipace's website touts its growing reach, expertise

September 17, 2012

Premium Lock SAS customer win; PPD allergy deal; new ATTUS service; DARA license deal; Chemring $49M contract

Bulldog Inside the Bulldog Blog: SAS wins XL Group as Visual Analytics customer; PPD to work with Europeans on allergies; ATTUS expands compliance services; DARA licenses topical gel; Chemring wins big defense contract.

Updated September 13, 2012

Premium Lock Quintiles ranks No. 6 in InformationWeek '500'

Lowe's, PPD, SAS, Bank of America and Martin Marietta also crack the top 200 in the annual ranking of information technology trend-setters as selected by InformationWeek magazine.

IW 500 IW 500

May 23, 2012

Premium Lock PPD hires Pfizer executive as its new CEO

David Simmons David Simmons will take over as the leader of the Wilmington-based life science services company on June 4. PPD has been without a CEO since December.

March 2, 2012

Premium Lock Raleigh-based INC Research tops life science service firm survey

INC Research  The study by Cary-based Industry Standard Research is possibly the most comprehensive measure of what pharmaceutical companies think about contract research organizations.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith